PRELUDE CAPITAL MANAGEMENT, LLC - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 58 filers reported holding PLURISTEM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$69,000
+27.8%
6,600
+8.2%
0.00%0.0%
Q2 2020$54,0006,1000.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 732,135$1,940,0000.83%
Green Alpha Advisors, LLC 61,759$164,0000.11%
Values First Advisors, Inc. 49,179$130,0000.08%
GSA CAPITAL PARTNERS LLP 257,684$683,0000.07%
SHELTON CAPITAL MANAGEMENT 240,000$636,0000.02%
Walleye Capital LLC 154,997$411,0000.01%
PDT Partners, LLC 59,400$157,0000.01%
Archford Capital Strategies, LLC 13,091$35,0000.01%
Susquehanna International Group Ltd. 13,164$35,0000.01%
MEITAV INVESTMENT HOUSE LTD 167,593$444,0000.01%
View complete list of PLURISTEM THERAPEUTICS INC shareholders